Assessing 4D Molecular Therapeutics: Insights From 5 Financial Analysts

Latest Ratings for FDMT

Date Firm Action From To
Jan 2022 SVB Leerink Initiates Coverage On Outperform
Jan 2021 B of A Securities Initiates Coverage On Buy
Jan 2021 Goldman Sachs Initiates Coverage On Neutral

View More Analyst Ratings for FDMT

View the Latest Analyst Ratings

read more

Leave a Reply

Your email address will not be published. Required fields are marked *